# Metabolic and Immune Vulnerability in Critically Ill Patients with Diabetes Mellitus

**Authors:** Mădălina Diana Daina (Fehér), Codrin Dan Nicolae Ilea, Cosmin Mihai Vesa, Alina Cristiana Venter, Adriana Vladu, Timea Claudia Ghitea, László Fehér, Cristian Marius Daina

PMC · DOI: 10.3390/medicina62020341 · Medicina · 2026-02-07

## TL;DR

Critically ill patients with diabetes who die in the ICU often have high blood sugar, immune issues, and organ failure, with lactate levels and need for ventilation being strong predictors of death.

## Contribution

Identifies metabolic and immune factors, along with ICU interventions, as key predictors of mortality in critically ill diabetic patients.

## Key findings

- Non-survivors had higher admission lactate, blood glucose, and creatinine, and lower lymphocyte counts.
- Mechanical ventilation and hemodialysis were independently associated with increased ICU mortality.
- A predictive model showed good discrimination (AUC = 0.87) for ICU mortality in diabetic patients.

## Abstract

Background and Objectives: Diabetes mellitus is frequently encountered in critically ill patients and is associated with increased short-term mortality. However, the biological and clinical determinants of mortality within the diabetic intensive care unit (ICU) population remain incompletely understood. This study aimed to evaluate laboratory parameters at ICU admission and key early ICU course variables, including acute complications and organ support interventions, associated with short-term ICU mortality in critically ill patients with diabetes mellitus. Materials and Methods: We conducted a retrospective observational cohort study including adult patients with diabetes mellitus admitted to a tertiary care ICU between January and December 2024. Demographic data, laboratory parameters at ICU admission, acute complications, and ICU interventions were collected. Patients were stratified according to ICU outcome (survivors vs. non-survivors). Univariate and multivariate logistic regression analyses were performed to identify independent predictors of ICU mortality. Model performance was assessed using the area under the receiver operating characteristic curve (AUC/ROC), Hosmer–Lemeshow test, and Brier score. Results: A total of 443 critically ill patients with diabetes mellitus were included, of whom 239 (54.0%) died during ICU hospitalization. Non-survivors exhibited higher admission blood glucose, lactate levels, and serum creatinine, as well as lower lymphocyte counts compared to survivors. Acute complications, including sepsis, acute kidney injury, and acute respiratory failure, were significantly more frequent among non-survivors. In multivariate analysis, admission lactate levels (OR = 1.02 per mg/dL increase), mechanical ventilation (OR = 47.30), and hemodialysis (OR = 3.38) remained independently associated with ICU mortality. The predictive model demonstrated good discrimination (AUC = 0.87) and adequate calibration. Conclusions: Critically ill patients with diabetes mellitus who do not survive ICU hospitalization present with early metabolic stress, immune dysregulation, and organ dysfunction. Admission lactate levels and the need for advanced organ support are key predictors of short-term mortality, supporting their role in risk stratification within the diabetic ICU population.

## Linked entities

- **Diseases:** Diabetes mellitus (MONDO:0005015), acute kidney injury (MONDO:0002492), acute respiratory failure (MONDO:0001208)

## Full-text entities

- **Diseases:** DM (MESH:D003920), lymphopenia (MESH:D008231), multisystem failure (MESH:D051437), immune impairment (MESH:D020274), Critically Ill (MESH:D016638), cardiometabolic disease (MESH:D024821), inflammation (MESH:D007249), injury to (MESH:D014947), hypoxemia (MESH:D000860), acute (MESH:D000208), metabolic disorders (MESH:D008659), metabolic dysregulation (MESH:D021081), hypercapnia (MESH:D006935), Acute kidney injury (MESH:D058186), metabolic and organ dysfunction (MESH:D009102), gestational diabetes (MESH:D016640), Acute respiratory failure (MESH:D012131), immune dysfunction (MESH:D007154), infection (MESH:D007239), Acute organ dysfunctions (MESH:D019965), death (MESH:D003643), Infectious complications (MESH:D003141), Sepsis (MESH:D018805), ill (MESH:D002908), immune dysregulation (OMIM:614878), dysfunction (MESH:D006331), Renal complications (MESH:D007674)
- **Chemicals:** Lactate (MESH:D019344), insulin (MESH:D007328), Blood glucose (MESH:D001786), oral antidiabetic agents (-), glucose (MESH:D005947), creatinine (MESH:D003404)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12942890/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12942890/full.md

## References

31 references — full list in the complete paper: https://tomesphere.com/paper/PMC12942890/full.md

---
Source: https://tomesphere.com/paper/PMC12942890